business

Lilly's Weight Loss Sets High Bar for Obesity Drug Race

Bloomberg Markets · Jun 9, 2026, 5:59 PM · Also reported by 1 other source

Sam Fazeli, Director of Research for Global Industries and Senior Pharmaceuticals Analyst for Bloomberg Intelligence, joined Bloomberg's Scarlett Fu and Paul Sweeney to discuss the gains and losses in the GLP1 market. (Source: Bloomberg)

Read full story on Bloomberg Markets → More top stories

Also covered by

Healthline AstraZeneca's New Oral GLP-1 Aids Weight Loss and Lowers Blood Sugar

Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Lilly's Weight Loss Sets High Bar for Obesity Drug Race

Also covered by

More in business